Skip to content

Novavax NVAX Change in Inventories

Change in Inventories at other companies

Moderna logo
ModernaMRNA
-$6M-175%
Merck & Co. logo
Merck & Co.MRK
$295M+41.3%
ALN
Alnylam PharmaceuticalsALNY
$3.32M+153%
Gilead Sciences logo
Gilead SciencesGILD
$52M-76.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$4.99M+2,798%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$4.85M+457%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's change in inventories?
Novavax (NVAX) reported change in inventories of $226K in Q1 2026.
How has Novavax's change in inventories changed year-over-year?
Novavax's change in inventories increased by 109.5% year-over-year, from -$2.38M to $226K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.